Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease-Reference-Cited by-同舟云学术

Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease

Published:2018-12-18 Issue:s1 Volume:8 Page:S65-S72
ISSN:1877-7171
Container-title:Journal of Parkinson's Disease
language:
Short-container-title:JPD

Author:

van Wamelen Daniel J.¹²³,Grigoriou Sotirios⁴,Chaudhuri K. Ray¹²,Odin Per⁴⁵

Affiliation:

1. Institute of Psychiatry, Psychology & Neuroscience at King’s College London, Department of Basic & Clinical Neuroscience, De Crespigny Park, London, United Kingdom

2. Parkinson Foundation International Centre of Excellence, King’s College Hospital, Denmark Hill, London, United Kingdom

3. Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Centre, Nijmegen, The Netherlands

4. University of Lund, Faculty of Medicine, Lund, Sweden

5. University Hospital Reinkenheide, Bremerhaven, Germany

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference50 articles.

1. Continuous dopamine-receptor treatment of Parkinson’s disease: Scientific rationale and clinical implications;Olanow;Lancet Neurol,2006

2. Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates;Bibbiani;Exp Neurol,2005

3. A five year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa;Rascol;N Engl J Med,2000

4. Continuous dopamine receptor stimulation in advanced Parkinson’s disease;Nutt;Trends Neurosci,2000

5. Nonmotor symptoms in experimental models of Parkinson’s disease;Titova;Int Rev Neurobiol,2017

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring in Parkinson’s disease;Journal of Neural Transmission;2024-09-03

2. Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways;Cell Communication and Signaling;2024-08-30

3. 20-Week intramuscular toxicity study of rotigotine behenate extended-release microspheres for injection via intramuscular injection in cynomolgus monkeys;Food and Chemical Toxicology;2024-08

4. A Comprehensive Approach to Parkinson’s Disease: Addressing Its Molecular, Clinical, and Therapeutic Aspects;International Journal of Molecular Sciences;2024-06-29

5. Tailored Monoacyl Poly(2-oxazoline)- and Poly(2-oxazine)-Lipids as PEG-Lipid Alternatives for Stabilization and Delivery of mRNA-Lipid Nanoparticles;Biomacromolecules;2024-06-26